February 27, 2026 · Form 4 insider transaction
Krishnan Suma bought 26,250 shares of Krystal Biotech, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 4 days after the transaction.
These same shares are also being reported on a Form 4 by the Reporting Person's spouse, Krish S. Krishnan.; 52,500 PSUs were granted on February 29, 2024, to the Reporting Person's spouse, Krish S. Krishnan. Each PSU represented a contingent right to receive one share of the Company's common stock, subject to the achievement of certain performance criteria during the year ended December 31, 2024, as approved by the Company's Compensation Committee, and the Reporting Person's spouse continued service to the Company on each applicable vesting date following such achievement. The PSUs vested ratably over a two-year period. All of the performance criteria were achieved and the remaining one-half of the PSUs granted, or 26,250 PSUs, vested on February 27, 2026.; Directly beneficially owned by Krish S. Krishnan, the spouse of the Reporting Person.